Ocular Therapeutix, Inc. (OCUL) has a consensus analyst rating of Buy, based on 18 analysts covering the stock. Of those, 16 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for OCUL is $25.50, representing a +191.1% upside from the current price of $8.76. Price targets range from a low of $21.00 to a high of $30.00.
